Patents by Inventor Samy O. Meroueh

Samy O. Meroueh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating human papilloma virus infections
    Patent number: 11931356
    Abstract: The invention provides compositions, compounds, formulations, and methods for treating HPV infections including pre-malignant infections and cancer. Compounds that covalently bind to the HPV E6 protein are disclosed.
    Type: Grant
    Filed: November 30, 2022
    Date of Patent: March 19, 2024
    Assignees: The Trustees of Indiana University, Kovina Therapeutics, Inc.
    Inventors: Elliot J. Androphy, Samy O. Meroueh, Zhijian Lu
  • Compounds and methods for treating cancer by inhibiting the urokinase receptor
    Patent number: 9745288
    Abstract: Compounds and methods for treating or preventing cancer associated with binding to the urokinase receptor are provided. Biological processes affected by the compounds include cell migration, cell growth, cell adhesion, angiogenesis, cancer cell invasion, apoptosis, tumor formation, tumor progression, metastasis, degradation of the extracellular matrix, pericellular proteolysis, activation of plasminogen, changes in the levels of an extracellular protease, and changes in the levels of a VEGF receptor.
    Type: Grant
    Filed: August 16, 2012
    Date of Patent: August 29, 2017
    Assignee: Indiana University Research and Technology Corporation
    Inventor: Samy O. Meroueh
  • COMPOUNDS AND METHODS FOR TREATING CANCER BY INHIBITING THE UROKINASE RECEPTOR
    Publication number: 20150051247
    Abstract: Compounds and methods for treating or preventing cancer associated with binding to the urokinase receptor are provided. Biological processes affected by the compounds include cell migration, cell growth, cell adhesion, angiogenesis, cancer cell invasion, apoptosis, tumor formation, tumor progression, metastasis, degradation of the extracellular matrix, pericellular proteolysis, activation of plasminogen, changes in the levels of an extracellular protease, and changes in the levels of a VEGF receptor.
    Type: Application
    Filed: August 16, 2012
    Publication date: February 19, 2015
    Inventor: Samy O. Meroueh